On the basis of the model for hypokalemia-induced ventricular arrhythmias in Figure 2, we suggest CaMKII inhibition, NKA activation, and in particular NKAα2 activation, to be further investigated as future antiarrhythmic strategies. This evidence concerns the gene TAC1 and Hypokalemia.